Anixa Biosciences
ANIX
22 hedge funds and large institutions have $5.53M invested in Anixa Biosciences in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 4 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
24% more capital invested
Capital invested by funds: $4.44M → $5.53M (+$1.09M)
5% more funds holding
Funds holding: 21 → 22 (+1)
0.11% less ownership
Funds ownership: 7.68% → 7.57% (-0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$227K |
| 2 |
PTP
Platform Technology Partners
New York
|
+$50.3K |
| 3 |
HPCM
Hunter Perkins Capital Management
Lombard,
Illinois
|
+$44.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$36.4K |
| 5 |
Bank of New York Mellon
New York
|
+$31.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$147K |
| 2 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
-$129K |
| 3 |
Two Sigma Investments
New York
|
-$96K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$75K |
| 5 |
Two Sigma Advisers
New York
|
-$65.9K |
ANIX Hedge Fund Activity: Q4 2020 in Review
22 of the 5,675 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q4 2020, worth a combined $5.53M — up 24% from $4.44M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ANIX positions and 4 closed out — a net gain of 1 holder — while 8 added to existing stakes and 6 trimmed.
The largest buyer was UBS Group, adding an estimated $227K. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $147K.
- 22 institutional investors held Anixa Biosciences (ANIX) as of Q4 2020, up from 21 in Q3 2020.
- Funds reported $5.53M of Anixa Biosciences stock for Q4 2020, up 24% quarter-over-quarter.
- 5 funds opened new Anixa Biosciences positions in Q4 2020 and 4 closed out, a net change of +1 holder.
- The largest Anixa Biosciences buyer in Q4 2020 was UBS Group, an estimated $227K added.
- The largest Anixa Biosciences seller in Q4 2020 was Qube Research & Technologies (QRT), an estimated $147K sold.
Based on aggregated 13F filings for Q4 2020.